GRDN
Guardian Pharmacy Services, Inc.
NYSEUSDEQUITY
DELAYED
Last price
37.93
▲ 0.45 (1.20%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
37.87
Prev close
37.48
Day high
38.11
Day low
36.90
Volume
223.06K
Market cap
—
P/E (TTM)
—
52W range
23.14 – 47.02
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
-1.30%
+0.1%
1M
-3.83%
-7.6%
3M
-1.15%
-4.2%
6M
+13.09%
+2.0%
YTD
+26.06%
+13.8%
1Y
+45.60%
+25.6%
3Y
—
-74.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.45B | $1.23B | $1.05B | $908.91M | +17.9% |
| Operating revenue | $1.45B | $1.23B | $1.05B | $908.91M | +17.9% |
| Cost of revenue | $1.16B | $984.04M | $837.88M | $723.04M | +17.5% |
| Gross profit | $292.72M | $244.37M | $208.31M | $185.87M | +19.8% |
| Selling, general & admin | $220.02M | $307.29M | $167.36M | $133.88M | -28.4% |
| Total operating expense | $220.02M | $307.29M | $167.36M | $133.88M | -28.4% |
| Operating income | $72.70M | -$62.92M | $40.95M | $51.99M | +215.5% |
| Net interest income | -$665.00K | -$3.28M | -$2.86M | -$1.93M | +79.7% |
| Pre-tax income | $73.42M | -$66.48M | $37.72M | $49.66M | +210.4% |
| Tax provision | $24.46M | $4.56M | $0 | — | +437.0% |
| Net income | $49.22M | -$87.29M | $23.90M | $35.42M | +156.4% |
| Net income to common | $49.22M | -$110.05M | $0 | $35.42M | +144.7% |
| Basic EPS | 0.79 | -1.77 | 0.00 | 0.58 | +144.6% |
| Diluted EPS | 0.78 | -1.77 | 0.00 | 0.58 | +144.1% |
| EBIT | $74.09M | -$63.20M | $40.58M | $51.59M | +217.2% |
| EBITDA | $96.42M | -$43.43M | $58.81M | $68.15M | +322.0% |
| Basic shares | 62.39M | 62.01M | 60.84M | 60.84M | +0.6% |
| Diluted shares | 63.30M | 62.01M | 60.84M | 60.84M | +2.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $65.62M | $4.66M | $752.00K | $607.00K | — | +1,308.1% |
| Cash & short-term investments | $65.62M | $4.66M | $752.00K | $607.00K | — | +1,308.1% |
| Accounts receivable | $101.61M | $97.15M | $77.26M | $67.83M | — | +4.6% |
| Inventory | $43.36M | $40.55M | $36.73M | $41.44M | — | +6.9% |
| Total current assets | $221.63M | $151.99M | $129.60M | $120.00M | — | +45.8% |
| Property, plant & equipment | $90.17M | $78.96M | $73.18M | $65.19M | — | +14.2% |
| Goodwill & intangibles | $98.22M | $84.21M | $68.03M | $70.49M | — | +16.6% |
| Total assets | $412.66M | $320.81M | $271.17M | $256.11M | — | +28.6% |
| Total current liabilities | $160.70M | $144.12M | $138.01M | $112.00M | — | +11.5% |
| Current debt | — | — | $12.98M | $7.96M | $3.71M | — |
| Long-term debt | — | — | $18.99M | $22.97M | $26.99M | — |
| Total debt | $37.14M | $30.13M | $61.00M | $56.81M | — | +23.3% |
| Total liabilities | $194.73M | $170.83M | $211.31M | $180.19M | — | +14.0% |
| Retained earnings | $66.34M | $17.12M | — | — | — | +287.4% |
| Shareholder equity | $205.76M | $142.67M | $0 | $0 | — | +44.2% |
| Working capital | $60.93M | $7.86M | -$8.41M | $7.99M | — | +674.8% |
| Net tangible assets | $107.54M | $58.46M | -$68.03M | -$70.49M | — | +83.9% |
| Shares issued | 63.32M | 63.29M | 60.84M | 60.84M | — | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $48.96M | -$71.03M | $37.72M | $49.66M | +168.9% |
| Depreciation & amortisation | $22.34M | $19.77M | $18.23M | $16.56M | +13.0% |
| Stock-based compensation | $13.85M | $131.49M | -$6.09M | -$3.38M | -89.5% |
| Change in working capital | $6.38M | -$29.41M | $15.60M | -$18.72M | +121.7% |
| Operating cash flow | $100.25M | $57.96M | $70.82M | $48.52M | +73.0% |
| Capital expenditure | -$19.55M | -$16.37M | -$14.56M | -$16.77M | -19.4% |
| Investing cash flow | -$32.23M | -$30.41M | -$13.44M | -$17.90M | -6.0% |
| Share buybacks | -$29.04M | -$55.18M | $0 | — | +47.4% |
| Dividends paid | $0 | -$35.75M | -$38.42M | -$30.80M | +100.0% |
| Financing cash flow | -$7.07M | -$23.64M | -$57.23M | -$45.03M | +70.1% |
| Free cash flow | $80.71M | $41.59M | $56.26M | $31.75M | +94.1% |
| End cash position | $65.62M | $4.66M | $752.00K | $607.00K | +1,308.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $351.77M | $336.60M | $397.62M | $377.43M | $344.33M | +4.5% |
| Operating revenue | $351.77M | $336.60M | $397.62M | $377.43M | $344.33M | +4.5% |
| Cost of revenue | $271.72M | $260.29M | $312.11M | $302.71M | $276.19M | +4.4% |
| Gross profit | $80.04M | $76.31M | $85.50M | $74.72M | $68.15M | +4.9% |
| Selling, general & admin | $59.40M | $58.63M | $54.74M | $58.37M | $55.57M | +1.3% |
| Total operating expense | $59.40M | $58.63M | $54.74M | $58.37M | $55.57M | +1.3% |
| Operating income | $20.64M | $17.68M | $30.76M | $16.35M | $12.58M | +16.8% |
| Net interest income | -$154.00K | -$154.00K | -$163.00K | -$160.00K | -$172.00K | 0.0% |
| Pre-tax income | $29.79M | $18.29M | $31.10M | $16.63M | $12.59M | +62.9% |
| Tax provision | $7.67M | $4.75M | $9.83M | $7.04M | $3.76M | +61.5% |
| Net income | $21.87M | $13.29M | $20.92M | $9.82M | $9.03M | +64.5% |
| Net income to common | $21.87M | $13.29M | $20.92M | $9.82M | $9.03M | +64.5% |
| Basic EPS | 0.35 | 0.21 | 0.33 | 0.16 | 0.15 | +66.7% |
| Diluted EPS | 0.34 | 0.21 | 0.33 | 0.15 | 0.14 | +61.9% |
| EBIT | $29.95M | $18.45M | $31.26M | $16.79M | $12.76M | +62.3% |
| EBITDA | $35.75M | $24.42M | $37.00M | $22.63M | $18.25M | +46.4% |
| Basic shares | 63.33M | 63.32M | 63.32M | 62.12M | 62.05M | +0.0% |
| Diluted shares | 63.84M | 63.69M | 63.62M | 63.43M | 63.20M | +0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $89.81M | $64.89M | $65.62M | $36.49M | $18.82M | +38.4% |
| Cash & short-term investments | $89.81M | $64.89M | $65.62M | $36.49M | $18.82M | +38.4% |
| Accounts receivable | $103.77M | $111.70M | $101.61M | $106.19M | $94.13M | -7.1% |
| Inventory | $50.44M | $47.16M | $43.36M | $47.86M | $44.16M | +7.0% |
| Total current assets | $254.67M | $235.18M | $221.63M | $198.28M | $170.46M | +8.3% |
| Property, plant & equipment | $88.89M | $90.89M | $90.17M | $88.32M | $86.46M | -2.2% |
| Goodwill & intangibles | $96.36M | $97.22M | $98.22M | $98.48M | $93.75M | -0.9% |
| Total assets | $443.58M | $426.94M | $412.66M | $390.04M | $356.33M | +3.9% |
| Total current liabilities | $154.04M | $160.54M | $160.70M | $161.95M | $143.99M | -4.0% |
| Total debt | $35.24M | $36.88M | $37.14M | $34.08M | $33.70M | -4.5% |
| Total liabilities | $185.94M | $194.52M | $194.73M | $194.54M | $176.66M | -4.4% |
| Retained earnings | $101.51M | $79.64M | $66.34M | $45.42M | $35.60M | +27.5% |
| Shareholder equity | $245.61M | $220.89M | $205.76M | $183.76M | $169.56M | +11.2% |
| Working capital | $100.63M | $74.64M | $60.93M | $36.33M | $26.47M | +34.8% |
| Net tangible assets | $149.25M | $123.67M | $107.54M | $85.27M | $75.81M | +20.7% |
| Shares issued | 63.32M | 63.32M | 63.32M | 63.32M | 63.30M | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $22.12M | $13.54M | $21.27M | $9.59M | $8.83M | — | +63.3% |
| Depreciation & amortisation | $5.81M | $5.98M | $5.74M | $5.84M | $5.49M | — | -2.8% |
| Stock-based compensation | $2.93M | $1.86M | $1.08M | $4.36M | $4.45M | — | +57.5% |
| Change in working capital | -$2.74M | -$16.30M | $2.19M | $6.31M | -$405.00K | — | +83.2% |
| Operating cash flow | $30.02M | $6.06M | $34.60M | $28.17M | $19.94M | — | +395.3% |
| Capital expenditure | -$4.62M | -$5.02M | -$4.23M | -$5.21M | -$4.31M | — | +8.0% |
| Investing cash flow | -$4.31M | -$4.75M | -$4.71M | -$8.97M | -$13.00M | — | +9.3% |
| Share buybacks | $0 | -$30.28M | $0 | $0 | -$29.04M | — | +100.0% |
| Dividends paid | — | — | $0 | $0 | $0 | $0 | — |
| Financing cash flow | -$805.00K | -$2.04M | -$758.00K | -$1.53M | -$2.11M | — | +60.5% |
| Free cash flow | $25.41M | $1.04M | $30.37M | $22.96M | $15.63M | — | +2,336.0% |
| End cash position | $89.81M | $64.89M | $65.62M | $36.49M | $18.82M | — | +38.4% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
38.61
-1.75% from price
SMA 20
39.81
-4.73% from price
SMA 50
40.51
-6.37% from price
SMA 100
39.23
-3.33% from price
SMA 200
35.34
+7.34% from price
EMA 12
38.76
-2.14% from price
EMA 26
39.49
-3.96% from price
EMA 50
39.65
-4.34% from price
RSI (14)
42.4
Neutral
MACD (12,26,9)
-0.73
Hist -0.28
ATR (14)
2.02
5.34% of price
Realised vol 30D
46.1%
Annualised
Bollinger upper
43.12
20, 2σ
Bollinger lower
36.50
20, 2σ
50 / 200 cross
Golden
40.51 vs 35.34
Trend bias
Above 200
+7.34%
Risk profile
Beta vs SPY
0.72
Less volatile than market
Correlation to SPY
0.22
Largely independent
Realised vol 30D
46.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-22.7%
Peak to trough
Max drawdown 5Y
-27.2%
Peak to trough
ATR 14
2.02
5.34% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference
Business Wire · 3d ago
Guardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript
Motley Fool · 9d ago
Guardian Pharmacy Services (GRDN) As Strong Results And Higher Outlook Recast The Valuation Story
Simply Wall St. · 13d ago
Why Guardian Pharmacy Services (GRDN) Is Up 10.9% After Raising 2026 Revenue Guidance And Expanding Footprint
Simply Wall St. · 14d ago
Guardian Pharmacy Services Q2 Earnings Call Highlights
MarketBeat · 15d ago
Oppenheimer Adjusts PT on Guardian Pharmacy Services to $49 From $43, Maintains Outperform Rating
MT Newswires · 15d ago
Guardian Pharmacy Services Raises 2026 Outlook After Strong Second Quarter
InvestorsHub · 15d ago
Guardian Pharmacy Services Inc (GRDN) (Q2 2026) Earnings Call Highlights: Raised Guidance and ...
GuruFocus.com · 16d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.